Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in […]
New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP Read Post »
Annual Drug Patent Expirations for OMIDRIA Omidria is a drug marketed by Rayner Surgical and is included in one NDA.
New patent expiration for Rayner Surgical drug OMIDRIA Read Post »
Annual Drug Patent Expirations for SEASONIQUE Seasonique is a drug marketed by Teva Branded Pharm and is included in one
New patent expiration for Teva Branded drug SEASONIQUE Read Post »
Annual Drug Patent Expirations for LINZESS Linzess is a drug marketed by Abbvie and is included in one NDA. It
Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA.
New patent expiration for Myovant Sciences drug MYFEMBREE Read Post »
Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Sumitomo Pharma and is included in one NDA.
New patent expiration for Sumitomo Pharma drug ORGOVYX Read Post »
Annual Drug Patent Expirations for TORISEL Torisel is a drug marketed by Pf Prism Cv and is included in one
EVOCLIN (clindamycin phosphate) Mylan Patent: 7,374,747 Expiration: Jan 23, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of January 21, 2024 Read Post »
Annual Drug Patent Expirations for EVOCLIN Evoclin is a drug marketed by Mylan and is included in one NDA. There
Get fresh news and insights, drug patent expirations & more…
